Qardio on Tuesday announced the launch of QardioCore, the first wearable medical electrocardiogram (ECG) monitor, which the company said allows "users to proactively look after their heart health long-term, all without the need for wires or patches." Chief technology officer Rosario Iannella described QardioCore as "a game-changer for doctors, patients and health conscious individuals, and a big step towards preventative health."
Qardio explained that QardioCore, worn as a chest strap, records continuous ECG, heart rate, heart rate variability, respiratory rate, temperature and activity data, which can then be easily shared with medical professionals and others. The company noted that the device pairs with its Qardio app for iOS.
"Cardiovascular health is the biggest health challenge in the developed world and with QardioCore, we make it easier, better and more cost-effective for everyone," stated Iannella. He added that "the ability to view and analyse such important data remotely and in context, as it is being generated, can substantially enhance the diagnostic yield."
The company indicated that the device is priced at $449 and will be available for sale in the US only after receiving FDA clearance. QardioCore will also be sold for 499 euros ($520) in Europe and 449 pounds ($550) in the UK. According to Qardio's website, QardioCore is slated to be shipped in the US and Europe in April.
To read more Top Story articles, click here.